Abstracts

INTEGRATING ANTIRETROVIRAL TREATMENT AND HARM REDUCTION SERVICES ON HIV AND OVERDOSE

The HIV epidemic in Tijuana, Mexico is concentrated in key populations, including people who inject drugs (PWID). Mexico’s drug law reform included referral to drug treatment, yet funding was provided for non-evidence based compulsory abstinence programs (CAP) associated with elevated HIV and overdose risk.  However, evidence-based opioid agonist therapy (OAT) reduces overdose, HIV transmission, and…

BUPRENORPHINE VS METHADONE AND ART PRESCRIBING IN VIETNAM: A RANDOMIZED TRIAL

Integrating methadone or buprenorphine treatment of opioid use disorder (OUD) into HIV care is a recommended strategy for achieving UNAIDS 90-90-90 targets, and associated with improved antiretroviral therapy [ART] uptake in observational studies and a single-site U.S. trial, but adoption of HIV clinic-based buprenorphine has been limited in many countries. We hypothesized that HIV-infected persons…

HRSA’S RYAN WHITE HIV/AIDS PROGRAM RESPONSE TO THE OPIOID EPIDEMIC

The U.S. is in the midst of an unprecedented opioid crisis with injection drug use (IDU)-related HIV outbreaks increasing, particularly in rural areas. The Health Resources and Services Administration’s Ryan White HIV/AIDS Program (HRSA RWHAP) is well positioned to integrate treatment for IDU-associated HIV infections with treatment for drug use disorders. The purpose of this…

IMPROVING HIV CASE-FINDING WITH MACHINE LEARNING

Alliance for Public Health implements social network strategy for HIV case-finding among key populations. We developed a model to improve recruitment of undiagnosed HIV-positives in the network using machine learning (ML) algorithm. Since 2016, 130,095 people who inject drugs and their extended risk network peers were recruited in 12 regions of Ukraine. Recruitment starts from HIV positive…